Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index; 26 of the 48 sources its claims cite were checked for support.
Abstract
Candida albicans is the leading fungal pathogen of humans, causing life-threatening disease in immunocompromised individuals. Treatment of candidiasis is hampered by the limited number of antifungal drugs whose efficacy is compromised by host toxicity, fungistatic activity, and the emergence of drug resistance. We previously established that the molecular chaperone Hsp90, which regulates the form and function of diverse client proteins, potentiates resistance to the azoles in C. albicans and in the model yeast Saccharomyces cerevisiae. Genetic studies in S. cerevisiae revealed that Hsp90's role in azole resistance is to enable crucial cellular responses to the membrane stress exerted by azoles via the client protein calcineurin. Here, we demonstrate that Hsp90 governs cellular circuitry required for resistance to the only new class of antifungals to reach the clinic in decades, the echinocandins, which inhibit biosynthesis of a critical component of the fungal cell wall. Pharmacological or genetic impairment of Hsp90 function reduced tolerance of C. albicans laboratory strains and resistance of clinical isolates to the echinocandins and created a fungicidal combination. Compromising calcineurin function phenocopied compromising Hsp90 function. We established that calcineurin is an Hsp90 client protein in C. albicans: reciprocal co-immunoprecipitation validated physical interaction; Hsp90 inhibition blocked calcineurin activation; and calcineurin levels were depleted upon genetic reduction of Hsp90. The downstream effector of calcineurin, Crz1, played a partial role in mediating calcineurin-dependent stress responses activated by echinocandins. Hsp90's role in echinocandin resistance has therapeutic potential given that genetic compromise of C. albicans HSP90 expression enhanced the efficacy of an echinocandin in a murine model of disseminated candidiasis. Our results identify the first Hsp90 client protein in C. albicans, establish an entirely new role for Hsp90 in mediating resistance to echinocandins, and demonstrate that targeting Hsp90 provides a promising therapeutic strategy for the treatment of life-threatening fungal disease.
Overview
CoChat Summary
## TL;DR
Hsp90 is required for *Candida albicans* tolerance to echinocandins, and this effect depends largely on calcineurin. Genetic or pharmacological impairment of Hsp90 or calcineurin made micafungin more effective in vitro and in a murine disseminated infection model.
## Key findings
- In antifungal susceptibility and spotting assays, inhibiting Hsp90 with geldanamycin (GdA) or radicicol (RAD) “dramatically enhanced” sensitivity to micafungin (MF) in two strains, and comparable effects were seen with caspofungin (CS).
- Compromising Hsp90 function made the tetO-HSP90/hsp90Δ strain hypersensitive to MF even without tetracycline, and restoring a wild-type HSP90 allele complemented both the reduced growth rate and MF hypersensitivity.
- Inhibiting calcineurin with cyclosporin A (CsA) or FK506 abolished MF tolerance; deleting CNA1 or CNB1 also abrogated MF tolerance, while CRZ1 deletion caused only a partial loss of MF tolerance.
- In the murine model, mice infected with the tetO-HSP90/hsp90Δ strain had significantly reduced kidney fungal burden than mice infected with wild-type HSP90 strain (P<0.05), and MF further reduced fungal burden in the tetO-HSP90/hsp90Δ group (P<0.001).
## Methods
- The study combined pharmacological inhibition (GdA, RAD, CsA, FK506) and genetic perturbation (HSP90, CNA1, CNB1, CRZ1 mutants; tetO-HSP90/hsp90Δ; MAL2p-HSP90/hsp90Δ) in *C. albicans* and *S. cerevisiae*.
- Antifungal tolerance was measured using modified broth microdilution MIC assays, checkerboard synergy assays, and spotting assays on liquid and solid media with MF and CS.
- Mechanistic tests included β-galactosidase reporter assays for calcineurin activation, co-immunoprecipitation of tagged Hsp90 and Cna1, immunoblotting for protein levels, and a tail-vein murine disseminated candidiasis model with kidney CFU readout.
## Limitations
- The paper explicitly notes that the basis for the different responses with micafungin and caspofungin on solid medium is unclear, and the response with anidulafungin “remains to be determined.”
- The authors state that synergy between Hsp90/calcineurin inhibitors and MF was not observed for all echinocandin-resistant clinical isolates tested; of 14 FKS1 mutants, synergy was observed for 8.
- Evidence on cidality was limited by MF-induced clumping, which made CFU counts inaccurate in the echinocandin killing assay; this is stated in the paper.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
19 Valid · 3 Not valid · 19 Not checked · 75 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“This antibody also demonstrated synergy with the echinocandin caspofungin in a murine model [53].”
§ Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin > Discussion
What the sources say
- Supportedcites [53] S Hodgetts, 2008, Efungumab and caspofungin: pre-clinical data supporting synergy., J Antimicrob Chemother source
The Introduction identifies efungumab as a human recombinant antibody fragment against Hsp90. The Abstract reports a statistically significant improvement with efungumab plus caspofungin in mice infected with fluconazole-resistant C. albicans, supporting the claimed synergy in a murine model. (LLM, conf=0.93)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Current Hsp90 inhibitors that are well-tolerated in humans as anti-cancer agents exhibit toxicity in the mouse model in the context of an acute fungal infection [22].”
§ Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin > Discussion
What the sources say
- Supportedcites [22] LE Cowen, 2009, Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease., Proc Natl Acad Sci U S A source
The Discussion states that Hsp90 inhibitors in clinical development as anticancer agents are well tolerated in humans. It also reports significant toxicity with two structurally unrelated Hsp90 inhibitors in a mouse model of acute disseminated C. albicans infection. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, in an invertebrate model of fungal pathogenesis, these pharmacological inhibitors of Hsp90 function enhance the efficacy of the two most widely deployed classes of antifungal drugs, azoles and echinocandins, against the two leading fungal pathogens of humans, Candida albicans and Aspergillus fumigatus [22].”
§ Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin > Discussion
What the sources say
- Supportedcites [22] LE Cowen, 2009, Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease., Proc Natl Acad Sci U S A source
The Abstract describes improved efficacy of fluconazole plus Hsp90 inhibitors against C. albicans in Galleria mellonella larvae, and improved larval survival with an Hsp90 inhibitor plus caspofungin against A. fumigatus. The Discussion likewise reports that combination therapy rescued lethal infections with both fungi in this invertebrate host. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“This recombinant antibody had therapeutic benefits in a clinical trial in combination with amphotericin B, which targets ergosterol [52].”
§ Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin > Discussion
What the sources say
- Supportedcites [52] J Pachl, 2006, A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis., Clin Infect Dis source
The Abstract identifies Mycograb as a recombinant antibody against fungal heat shock protein 90 and reports better treatment responses when it was combined with lipid-associated amphotericin B than when amphotericin B was given with placebo. The Discussion likewise describes improved clinical and mycological resolution. These passages support the claimed therapeutic benefit in the clinical trial. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Consistent with previous findings [23], we confirmed that Hsp90 and calcineurin physically interact in S. cerevisiae (Figure 9A), as they do in C. albicans (Figure 4).”
§ Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin > Results > Divergence of Hsp90 and calcineurin's role in echinocandin tolerance in S. cerevisiae
What the sources say
- Supportedcites [23] J Imai, 2000, Role of HSP90 in salt stress tolerance via stabilization and regulation of calcineurin., Mol Cell Biol source
The Abstract reports that Hsc82, a yeast HSP90 homologue, coimmunoprecipitated with the calcineurin catalytic subunit Cna2 in Saccharomyces cerevisiae cells under normal conditions. The Discussion also says coimmunoprecipitation experiments revealed complexes of Cna2 with Hsp82 and Hsc82, supporting the attributed physical interaction. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
56 more claims · 1 with their cited sources checked
Create a free account to see all 116 claims and every source verdict.
- Probably not a substantial claim. 35
- It may state two separate claims as one. 27
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hsp90 enables crucial responses to drug-induced stress by orchestrating signaling through the protein phosphatase calcineurin and the protein kinase C (PKC) cell wall integrity signaling cascade [41], [46].”
From Global Analysis of the Evolution and Mechanism of Echinocandin Resistance in Candida glabrata (2012) · cites this paper as [41]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In C. albicans, key client proteins of Hsp90 include the Ca2+-calmodulin-activated protein phosphatase calcineurin, and multiple members of the PKC-MAPK cell wall integrity cascade (Pkc1, Bck1, Mkk2 and Mkc1)75–78.”
From Molecular mechanisms governing antifungal drug resistance (2023) · cites this paper as [76]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consequently, Hsp90 inhibition blocks the activation of calcineurin-dependent stress responses and PKC signalling, abrogating tolerance and resistance to the azole and echinocandin drugs76,78.”
From Molecular mechanisms governing antifungal drug resistance (2023) · cites this paper as [76]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hsp90 depletion phenocopies the azole sensitivity of calcineurin and protein kinase C mutants96,101.”
From Fungal Hsp90: a biological transistor that tunes cellular outputs to thermal inputs (2012) · cites this paper as [96]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In Candida albicans and Aspergillus fumigatus, role of Hsp90 in echinocandin resistance has been well established [10].”
From Heat shock protein 90 localizes to the surface and augments virulence factors of Cryptococcus neoformans (2017) · cites this paper as [10]
Experimental — accuracy not yet measured
26 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 1×
“and are responsible for a broad spectrum of disease [1,2].”
BackgroundGlobal analysis of protein expression in yeast
Ghaemmaghami, S., Huh, W.-K., Bower, K., Howson, R. W., Belle, A., Dephoure, N., O'Shea, E. K., & Weissman, J. S. (2003) · Nature · doi:10.1038/nature02046 · Cited by 3,750 · cited 1×
“cerevisiae [36].”
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304 · cited 1×
“fumigatus is the principal causal agent of invasive aspergillosis with alarming mortality rates up to 90% that still remain at 40% with the best current treatment options [25,26].”
BackgroundPratt, W. B., & Toft, D. O. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800201 · Cited by 1,483 · cited 1×
“Hsp90 is an essential chaperone that regulates the form and function of many key signal transducers [17–19].”
BackgroundWhitesell, L., Mimnaugh, E. G., De Costa, B., Myers, C. E., & Neckers, L. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8324 · Cited by 1,444 · cited 1×
“[32,33].”
Structure and mechanism of the Hsp90 molecular chaperone machinery
Pearl, L. H., & Prodromou, C. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142738 · Cited by 1,103 · cited 1×
“Hsp90 is an essential chaperone that regulates the form and function of many key signal transducers [17–19].”
BackgroundRoles of heat-shock proteins in innate and adaptive immunity.
Srivastava, P. (2002) · Nature reviews. Immunology · doi:10.1038/nri749 · Cited by 1,069 · cited 1×
“Consistent with this thinking, heat-shock proteins are immunodominant antigens for the recognition of many pathogens and play a central role in mediating both innate and adaptive immune responses [54,55].”
BackgroundRoe, S. M., Prodromou, C., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980403y · Cited by 1,004 · cited 1×
“[32,33].”
Zhao, R., Davey, M., Hsu, Y.-C., Kaplanek, P., Tong, A., Parsons, A. B., Krogan, N., Cagney, G., Mai, D., Greenblatt, J., et al. (2005) · Cell · doi:10.1016/j.cell.2004.12.024 · Cited by 819 · cited 2×
“cerevisiae [24], while to date not a single Hsp90 client protein has been characterized in C.”
BackgroundZaoutis, T. E., Argon, J., Chu, J., Berlin, J. A., Walsh, T. J., & Feudtner, C. (2005) · Clinical Infectious Diseases · doi:10.1086/496922 · Cited by 784 · cited 1×
“[2,3].”
Cited by
Items 201–300 of 364
Epigenetic and Posttranslational Modifications in Regulating the Biology of Aspergillus Species
Nie, X., Li, B., & Wang, S. (2018) · Advances in applied microbiology · doi:10.1016/bs.aambs.2018.05.004 · Cited by 23
Mechanisms of Azole Potentiation: Insights from Drug Repurposing Approaches
Xiong, J., Lu, H., & Jiang, Y. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00657 · Cited by 20
Antifungal resistance, combinations and pipeline: oh my!
Stover, K. R., Hawkins, B. K., Keck, J. M., Barber, K. E., & Cretella, D. A. (2023) · Drugs in Context · doi:10.7573/dic.2023-7-1 · Cited by 22
“106 Additionally, Lamoth et al. showed that exposure to the calcineurin inhibitor geldanamycin improved fungicidal activity of caspofungin against echinocandin-resistant A. fumigatus.”
BackgroundThe Ins and Outs of Azole Antifungal Drug Resistance: Molecular Mechanisms of Transport
Zavřel, M., Esquivel, B. D., & White, T. C. (2017) · Springer eBooks · doi:10.1007/978-1-4939-0694-9_29 · Cited by 24
“Since the cell wall integrity is also connected to calcineurin signaling, there is also synergistic effect of echinocandins with HSP90/calcineurin inhibitors, creating a fungicidal combination (Singh et al. 2009).”
BackgroundZhang, Y., He, K., Guo, X., Jiang, J., Qian, L., Xu, J., Che, Z., Huang, X., & Liu, S. (2023) · Journal of Fungi · doi:10.3390/jof9030334 · Cited by 20
“In a study of Candida albicans, several heat shock proteins were discovered and they were proven to have the potential to be a promising target for antifungal effects [51,52].”
BackgroundThe Significance of Mono‐ and Dual‐Effective Agents in the Development of New Antifungal Strategies
Zobi, C., & Algül, Ö. (2025) · Chemical Biology & Drug Design · doi:10.1111/cbdd.70045 · Cited by 27
Jia, Y., Tang, R.-J., Wang, L., Zhang, X., Wang, Y., Jia, X.-M., & Jiang, Y.-Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048369 · Cited by 19
“Several lines of evidence suggested that iron, AGE3 and HSP90 mediated antifungal drug susceptibilities cross talk with the calcineurin signaling pathway [17,32,33,34] and calcineurin could be targeted to enhance FLC therapy [16,35,36].”
BackgroundProtein-Protein Interactions in Candida albicans
Schoeters, F., & Dijck, P. V. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01792 · Cited by 21
Ceballos-Garzon, A., Monteoliva, L., Gil, C., Alvarez-Moreno, C., Vega-Vela, N. E., Engelthaler, D. M., Bowers, J., Le Pape, P., & Parra-Giraldo, C. M. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab454 · Cited by 18
Yang, F., Wang, Y., Yan, D., Liu, Z., Wei, B., Chen, J., & He, W. (2023) · Molecules · doi:10.3390/molecules28124792 · Cited by 20
A novel role of HSP90 in regulating osteoclastogenesis by abrogating Rab11b-driven transport
Tran, M. T., Okusha, Y., Feng, Y., Sogawa, C. A., Eguchi, T., Kadowaki, T., Sakai, E., Tsukuba, T., & Okamoto, K. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119096 · Cited by 19
Alber, J., Jiang, L., & Geyer, J. (2013) · Yeast · doi:10.1002/yea.2981 · Cited by 21
“albicans (Cunningham and Fink, 1996; Cowen and Lindquist, 2005; Cowen et al., 2006; Singh et al., 2009).”
InfluentialSun, Y., Gao, L., Yuan, M., Yuan, L., Yang, J. Y., & Zeng, T. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.576975 · Cited by 19
“fumigatus in murine models, respectively, and potentiates the treatment effect of caspofungin and fluconazole in invasive candidiasis (Cowen et al., 2009; Singh et al., 2009; Lamoth et al., 2014).”
BackgroundButyrolactol A enhances caspofungin efficacy via flippase inhibition in drug-resistant fungi
Chen, X., Duan, H. D., Hoy, M. J., Koteva, K. K., Spitzer, M., Guitor, A. K., Puumala, E., Fiebig‐Comyn, A., Hu, G., Yiu, B., et al. (2025) · Cell · doi:10.1016/j.cell.2025.11.036 · Cited by 27
Self-citationHsp90 interaction networks in fungi—tools and techniques
Crunden, J. L., & Diezmann, S. (2021) · FEMS Yeast Research · doi:10.1093/femsyr/foab054 · Cited by 18
“2009), drug resistance in planktonic cells (Singh et al. 2009) and biofilms (Robbins et al.”
BackgroundMarquez, L., Lee, Y., Duncan, D., Whitesell, L. J., Cowen, L. E., & Quave, C. L. (2023) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00113 · Cited by 19
Self-citationHossain, S., Veri, A. O., Liu, Z., Iyer, K. R., O’Meara, T. R., Robbins, N., & Cowen, L. E. (2021) · Genetics · doi:10.1093/genetics/iyab095 · Cited by 23
“Drug susceptibility assays were performed in flat-bottom, 96-well microtiter plates (Sarstedt) with a minimum of two technical replicates and in biological duplicate as previously described (Singh et al. 2009).”
BackgroundMethodSelf-citationCryptococcusantigens and immune responses: implications for a vaccine
Chaturvedi, A. K., & Wormley, F. L. (2013) · Expert Review of Vaccines · doi:10.1586/14760584.2013.840094 · Cited by 20
Functional Divergence of Hsp90 Genetic Interactions in Biofilm and Planktonic Cellular States
Diezmann, S., Leach, M. D., & Cowen, L. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137947 · Cited by 19
“albicans is the stress-responsive protein phosphatase calcineurin [17], which enables antifungal drug resistance when stabilized by Hsp90 [12].”
BackgroundSelf-citationEchinocandin Antifungal Drug Resistance in Candida Species: A Cause for Concern?
Sanguinetti, M., Posteraro, P., & Posteraro, B. (2010) · Current Infectious Disease Reports · doi:10.1007/s11908-010-0131-2 · Cited by 17
Steroid toxicity and detoxification in ascomycetous fungi
Cvelbar, D., Žist, V., Kobal, K., Žigon, D., & Žakelj‐Mavrič, M. (2012) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2012.11.025 · Cited by 17
“Stress proteins and steroid toxicity Heat shock protein Hsp90 has been found to be involved in antifungal resistance [29] therefore the possible role of stress proteins Hsp70 and Hsp90 in steroid hormone sensitivity was tested using S.”
MethodGenome-Wide Response to Drugs and Stress in the Pathogenic Yeast Candida glabrata
Pais, P., Galocha, M., & Teixeira, M. C. (2019) · Progress in molecular and subcellular biology · doi:10.1007/978-3-030-13035-0_7 · Cited by 18
Insight into the Mechanisms and Clinical Relevance of Antifungal Heteroresistance
Su, Y., Li, Y., Yi, Q., Xu, Y., Sun, T., & Li, Y. (2025) · Journal of Fungi · doi:10.3390/jof11020143 · Cited by 18
“In addition, activation of cellular stress response pathways, such as the heat shock protein (Hsp) and calcineurin pathways, has been shown to contribute to echinocandin tolerance in C. albicans [120,121].”
Recent innovations and challenges in the treatment of fungal infections
Liu, D., Zhou, R., & Gao, X. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1676009 · Cited by 26
Alaalm, L., Crunden, J. L., Butcher, M. C., Obst, U., Whealy, R. N., Williamson, C. E., O’Brien, H., Schaffitzel, C., Ramage, G., SPENCER, J. M., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.637836 · Cited by 18
“Hsp90 regulates cell morphology, drug resistance, and virulence in C. albicans (Singh et al., 2009) and other leading fungal pathogens of humans such Cryptococcus neoformans (Cordeiro et al., 2015), which causes brain infections, and Aspergillus fumigatus (Lamoth et al., 2012) which targets the…”
BackgroundKumar, A., Roy, A., Deshmukh, M. V., & Tamuli, R. (2019) · Archives of Microbiology · doi:10.1007/s00203-019-01768-z · Cited by 14
Xiong, J., Wang, L., Feng, Y., Zhen, C., Hang, S., Yu, J., Lu, H., & Jiang, Y. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122699 · Cited by 15
Fang, T., Xiong, J., Huang, X., Fang, X., Shen, X., Jiang, Y., & Lu, H. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127964 · Cited by 17
Ceballos-Garzón, A., Román, E., Plá, J., Pagniez, F., Amado, D., Alméciga-Díaz, C. J., Pape, P. L., & Parra‐Giraldo, C. M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265777 · Cited by 14
Nobile, C. J., Ennis, C. L., Hartooni, N., Johnson, A. D., & Lohse, M. B. (2020) · Microorganisms · doi:10.3390/microorganisms8050756 · Cited by 13
Molecular Mechanisms of Resistance to Antifungals in Candida albicans
Ruiz‐Baca, E., Arredondo-Sánchez, R. I., Corral-Pérez, K., López-Rodríguez, A., Meneses‐Morales, I., Ayala‐García, V. M., & Martínez-Rocha, A. L. (2021) · Infectious diseases · doi:10.5772/intechopen.96346 · Cited by 23
“Resistant strains are increasing in number for some classes of antifungal agents, particularly for azoles and echinocandins [53].”
BackgroundDrug design strategies for the treatment azole-resistant candidiasis
Moghimi, S., Shafiei, M., & Foroumadi, A. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.2098949 · Cited by 15
“were previously introduced in different signaling pathways, like protein kinase C (PKC) [38], casein kinase 2 (CK2) [39], calcineurin [40], rapamycin (TOR) kinases [41], and other fungal kinases have connections with Hsp90 [42,43].”
BackgroundAutophagy Alters the Susceptibility of Candida albicans Biofilms to Antifungal Agents
Shen, J., Ma, M., Duan, W., Huang, Y., Shi, B., Wu, Q., & Wei, X. (2023) · Microorganisms · doi:10.3390/microorganisms11082015 · Cited by 15
“Total protein extracts from the control and treated biofilms under antifungal agents for 24 h at the concentration of SMIC50 were prepared using an immunoprecipitation protocol for western blotting [27].”
MethodInterdisciplinary approaches for the discovery of novel antifungals
Yiu, B., Robbins, N., & Cowen, L. E. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.04.018 · Cited by 14
Self-citationCek1 regulates ß(1,3)-glucan exposure through calcineurin effectors in Candida albicans
Wagner, A. S., Lumsdaine, S. W., Mangrum, M. M., King, A. E., Hancock, T. J., Sparer, T. E., & Reynolds, T. B. (2022) · PLOS Genetics · doi:10.1371/journal.pgen.1010405 · Cited by 12
Calcineurin Inhibitors Synergize with Manogepix to Kill Diverse Human Fungal Pathogens
Liston, S. D., Whitesell, L., Kapoor, M., Shaw, K. J., & Cowen, L. E. (2022) · Journal of Fungi · doi:10.3390/jof8101102 · Cited by 12
“albicans: ATCC 90,028 (Clinical isolate) [31] SN95 (arg4/arg4, his1/his1, URA3/ura3::imm434, IRO1/iro1::imm434) [32] CaLC909 (As SN95, cna1::FRT/cna1::FRT) [33] CaSS1 (his3::hisG/his3::hisG, leu2::tetR-GAL4AD-URA3/LEU2) [34]”
Self-citationZheng, L., Xu, Y., Wang, C., & Guo, L. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1450557 · Cited by 14
Li, P., Seneviratne, C. J., Luan, Q., & Jin, L. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.639123 · Cited by 15
“HSP90 could facilitate the development of antifungal resistance in C. albicans and Saccharomyces cerevisiae (Cowen and Lindquist, 2005), and actually it governs echinocandin and azole resistance in C. albicans via activation of calcineurin (Singh et al., 2009).”
BackgroundYang, X., Pei, Z., Hu, R., Zhang, Z., Lou, Z., & Sun, X. (2021) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b20-00246 · Cited by 12
Čuperlović‐Culf, M., Loewen, M. C., Rajagopalan, N., & Surendra, A. (2017) · Plant Pathology · doi:10.1111/ppa.12726 · Cited by 13
“Inhibition of Hsp90s has been shown to increase the therapeutic efficacies of azoles and echinocandins against Candida albicans and Aspergillus fumigatus (Cowen et al., 2009; Singh et al., 2009; Lamoth et al., 2013).”
BackgroundCombating increased antifungal drug resistance in Cryptococcus, what should we do in the future?
Deng, H., Song, J., Huang, Y., Yang, C., Zang, X., Zhou, Y., Li, H., Dai, B., & Xue, X. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023011 · Cited by 15
“The calcineurin pathway [43], cell wall integrity (CWI) pathway [44], high osmolarity glycerol (HOG) pathway [45], and Hsp90 protein [46] enable cells to adapt to cell wall stress through cell wall compensatory biosynthesis and remodelling.”
BackgroundZhang, X., Cao, S., Li, W. L., Sun, H., Deng, Y., Zhang, A., & Chen, H. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.597998 · Cited by 11
“Son et al. (2011) reported that Fg01350 (GzC2H014) is a key transcription factor and that its mutant shows no perithecia development and multiple defects in virulence, growth, and toxin production.”
BackgroundThe SAGA and NuA4 component Tra1 regulates Candida albicans drug resistance and pathogenesis
Razzaq, I., Berg, M. D., Jiang, Y., Genereaux, J. L., Uthayakumar, D., Kim, G. H., Agyare-Tabbi, M. R., Halder, V., Brandl, C. J., Lajoie, P., et al. (2021) · Genetics · doi:10.1093/genetics/iyab131 · Cited by 11
Fallah, S., Duncan, D., Reichl, K. D., Smith, M. J., Wang, W., Porco, J. A. J., Brown, L. E., Whitesell, L. J., Robbins, N., & Cowen, L. E. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.04095-23 · Cited by 10
“To further interrogate the BU-CMD chemical library for antifungal activity, we screened an expanded collection of 3,049 compounds encompassing diverse chemo types at 25 µM in Roswell Park Memorial Institute (RPMI) 1640 medium against a clinical isolate of C. albicans , DPL-15 (9).”
MethodSelf-citationWhat ‘Omics can tell us about antifungal adaptation
Ribeiro, G. F., Denes, E., Heaney, H., & Childers, D. S. (2021) · FEMS Yeast Research · doi:10.1093/femsyr/foab070 · Cited by 11
“Hsp90 is also important in stabilizing calcineurin in S. cerevisiae and enables calcineurin-dependent responses to drug-induced cellular stresses; however, Hsp90 does not appear to modulate echinocandin susceptibility in this yeast (Singh et al. 2009; Singh-Babak et al. 2012).”
BackgroundBrown, A. J. P., Cowen, L. E., Pietro, A. D., & Quinn, J. (2017) · ASM Press eBooks · doi:10.1128/9781555819583.ch21 · Cited by 15
Self-citationLin, Y., Jung, H., Bulman, C. A., Ng, J., Vinck, R., O’Beirne, C., Zhong, S., Moser, M. S., Tricoche, N., Peguero, R., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01333 · Cited by 11
Stephanoascus ciferrii Complex: The Current State of Infections and Drug Resistance in Humans
Cosio, T., Pica, F., Fontana, C., Pistoia, E. S., Favaro, M., Valsecchi, I., Zarabian, N., Campione, E., Botterel, F., & Gaziano, R. (2024) · Journal of Fungi · doi:10.3390/jof10040294 · Cited by 19
Heat Shock Protein 90 (Hsp90) in Fungal Growth and Pathogenesis
Lamoth, F., Juvvadi, P. R., & Steinbach, W. J. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0195-9 · Cited by 12
Prasad, P., Jain, N., Chaudhary, J., Thakur, R. K., Savadi, S., Bhardwaj, S. C., Gangwar, O. P., Lata, C., Adhikari, S., Kumar, S., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1143703 · Cited by 9
“Four of these proteins have various role as: (i) stress-induced-phosphoprotein 1 {STIP1, also known as heat shock protein 70/90 (HSP70/90)} is known to regulate different cellular and physiological processes including cell morphology, drug resistance, and virulence in eukaryotes (Singh et al., 2009; Alaalm et al., 202…”
BackgroundSensitivity of White and Opaque Candida albicans Cells to Antifungal Drugs
Craik, V., Johnson, A. D., & Lohse, M. B. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00166-17 · Cited by 10
Wang, Y., Shi, H., Dong, S., Li, Y., Wang, M., Huai, Y., Zhang, X., Chen, X., Mao, C., Gao, X., et al. (2017) · Nano Research · doi:10.1007/s12274-017-1845-3 · Cited by 9
Das, S., Goswami, A. M., & Saha, T. (2022) · Microbial Pathogenesis · doi:10.1016/j.micpath.2022.105418 · Cited by 9
Sah, S. K., Bhattacharya, S., Yadav, A., Husain, F., Ndiaye, A. B. K. T., Kruppa, M., Hayes, J. J., & Rustchenko, E. P. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00977-22 · Cited by 11
A novel calcineurin-independent activity of cyclosporin A in Saccharomyces cerevisiae
Singh-Babak, S. D., Shekhar, T., Smith, A. M., Giaever, G. N., Nislow, C., & Cowen, L. E. (2012) · Molecular BioSystems · doi:10.1039/c2mb25107h · Cited by 9
Self-citationEchinocandin resistance in human pathogenic fungi
Munro, C. A. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.171 · Cited by 9
Maranhão, F. C. D. A., Silveira, H. C. S., Rossi, A., & Martinez-Rossi, N. M. (2011) · Canadian Journal of Microbiology · doi:10.1139/w11-011 · Cited by 13
Kumari, S., Kumar, M., Esquivel, B. D., Wasi, M., Pandey, A. K., Khandelwal, N., Mondal, A. K., White, T. C., Prasad, R., & Gaur, N. A. (2022) · mBio · doi:10.1128/mbio.03545-21 · Cited by 9
Strategies to manage antifungal drug resistance
Tseng, H.-K., & Perfect, J. R. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.517195 · Cited by 11
“albicans [97,98].”
Self-citationCandida albicans: a historical overview of investigations into an important human pathogen
Shrivastava, M., & Whiteway, M. S. (2025) · Canadian Journal of Microbiology · doi:10.1139/cjm-2025-0036 · Cited by 7
The PP2A Catalytic Subunit PPH21 Regulates Biofilm Formation and Drug Resistance of Candida albicans
Shen, J., Li, Y., & Miao, H. (2025) · Microorganisms · doi:10.3390/microorganisms13092093 · Cited by 6
“Protein extracts from the C. albicans biofilm were isolated via immunoprecipitation for the Western blot analysis [29].”
Candida auris vacuolar calcium pump mediates fluconazole efflux and resistance evolution
Song, Y., Chen, J., Wan, J., Zhang, J., Liu, Q., Sun, F., Zhang, H., Guo, Y., Chow, E. W. L., Chen, Y., et al. (2026) · Nature Microbiology · doi:10.1038/s41564-026-02270-1 · Cited by 8
Rouges, C., Asad, M., Laurent, A. D., Marchand, P., & Pape, P. L. (2023) · Microorganisms · doi:10.3390/microorganisms11122837 · Cited by 8
Mechanisms of Resistance to Antifungal Agents
Perlin, D. S. (2015) · ASM Press eBooks · doi:10.1128/9781555817381.ch130 · Cited by 9
Mechanisms of Drug Resistance in Candida albicans
Sanglard, D. (2017) · Springer eBooks · doi:10.1007/978-3-319-50409-4_15 · Cited by 11
Calcium: a central player in Cryptococcus biology
Squizani, E. D., Reuwsaat, J. C. V., Motta, H., Tavanti, A. G., & Kmetzsch, L. (2021) · Fungal Biology Reviews · doi:10.1016/j.fbr.2021.03.004 · Cited by 12
Lefranc, M., Accoceberry, I., Fitton‐Ouhabi, V., Biteau, N., & Noël, T. (2023) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkad359 · Cited by 8
In vitro interactions between 17‐ AAG and azoles against Exophiala dermatitidis
Gao, L., Sun, Y., He, C., Li, M., & Zeng, T. (2018) · Mycoses · doi:10.1111/myc.12824 · Cited by 7
Post-transcriptional control of antifungal resistance in human fungal pathogens
Sharma, C., & Kadosh, D. (2023) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2080527 · Cited by 6
“Singh et al. demonstrated a role for Hsp90 in regulating the cellular circuitry required for resistance to the echinocandins (Singh et al. 2009).”
BackgroundInfluentialCandida albicans Biofilms, Heterogeneity and Antifungal Drug Tolerance
LaFleur, M. D. (2011) · The Open Mycology Journal · doi:10.2174/1874437001105010021 · Cited by 9
Candida albicans Mrv8, is involved in epithelial damage and biofilm formation
Costa, A. C. B. P., Back‐Brito, G. N., Mayer, F. L., Hube, B., & Wilson, D. (2020) · FEMS Yeast Research · doi:10.1093/femsyr/foaa033 · Cited by 6
“The mechanisms of biofilm antifungal resistance are not yet fully understood, but the resistant phenotype has been linked to overexpression of drug targets, higher cell density, heterogeneous populations of cells with different growth rates, expression of efflux pumps (CDR1– 2 and MDR1), extracellular matrix (especial…”
BackgroundMiranda, I. M., Gonçalves, M. F. M., Pinheiro, D., Hilário, S., Paiva, J. A., Guimarães, J. T., & Costa‐de‐Oliveira, S. (2025) · Journal of Fungi · doi:10.3390/jof11100716 · Cited by 8
“CRZ1 is a transcription factor involved in stress response and cell wall integrity, whose role in drug resistance is still controversial among Candida species [34,62,63].”
Update on Antifungal Resistance and its Clinical Impact
Posteraro, B., Posteraro, P., & Sanguinetti, M. (2013) · Current Fungal Infection Reports · doi:10.1007/s12281-013-0143-0 · Cited by 5
Calcineurin controls the cytokinesis machinery during thermal stress in Cryptococcus deneoformans
Yadav, V., Averette, A. F., Upadhya, R., & Heitman, J. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2503751122 · Cited by 8
“Calcineurin has been shown to interact with Hsp90 in C. albicans , specifically as a client of Hsp90 ( 36 ) whereas its interactions with Hsp70 are not well - defined.”
Mechanisms Of Dermatophyte Resistance To Antifungal Substances
Łagowski, D., Gnat, S., & Nowakiewicz, A. (2020) · Postępy Mikrobiologii - Advancements of Microbiology · doi:10.21307/pm-2020.59.2.012 · Cited by 7
RetractedYeast Biofilms in the Context of Human Health and Disease
Raut, J. S., Doke, S. K., & Karuppayil, S. M. (2017) · Springer eBooks · doi:10.1007/978-981-10-2621-8_6 · Cited by 6
Bois, A. C. D., Xue, A., Pham, C., Revie, N. M., Meyer, K. J., Yashiroda, Y., Boone, C. M., Nodwell, J. R., Stogios, P. J., Savchenko, A. V., et al. (2022) · mSphere · doi:10.1128/msphere.00075-22 · Cited by 7
“In contrast, DPL15 is a strain harboring mutations in the echinocandin drug target gene FKS1 (10) (Fig.”
BackgroundSelf-citationThe Ins and Outs of Azole Antifungal Drug Resistance: Molecular Mechanisms of Transport
Zavřel, M., Esquivel, B. D., & White, T. C. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0667-3_29-1 · Cited by 7
Antifungal Resistance: Cellular and Molecular Mechanisms
Araújo, R., & Espinel‐Ingroff, A. (2010) · Springer eBooks · doi:10.1007/978-3-642-12173-9_7 · Cited by 6
Shen, J., Weng, C., Zhu, S., Chen, W., Xiong, X., & Wei, X. (2025) · International Dental Journal · doi:10.1016/j.identj.2025.103873 · Cited by 4
Wei, Y., Wang, J., Tang, N., Lin, Z., Li, W., Xu, Y., & Guo, L. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1618815 · Cited by 7
Lukumay, N. R., Li, Y., Wang, H., & Wei, W. (2025) · Virulence · doi:10.1080/21505594.2025.2569624 · Cited by 8
“Inhibiting Hsp90 reduces resistance and enhances the efficacy of echinocandin [92–94].”
Overcoming Candida biofilm resistance: targeting persister cells with probiotic-derived metabolites
Debta, P., Sahu, B. K., Patra, S. K., Debta, F. M., Mishra, E., & Panda, S. K. (2026) · Frontiers in Antibiotics · doi:10.3389/frabi.2026.1767028 · Cited by 8
Zhang, M., Zhao, Y., Cui, H., Huang, W., Xiong, K., Yang, S., Duan, Y., He, Y., Yang, L., Su, C., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2417721122 · Cited by 5
“It is well established that Hsp90 enables echinocandin tolerance through stabilizing its client proteins such as calcineurin ( 23 ).”
Sah, S. K., Yadav, A., Kruppa, M., & Rustchenko, E. P. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03295-23 · Cited by 5
“On the other hand, we find that Hsp90p, of which calcineurin is a client protein (37, 38) and is a conserved molecular chaperone that facilitates the folding and function of hundreds of client proteins reviewed in reference (39), is involved with the regulation of four genes RPO26 and DUS4…”
BackgroundBende, G., Zsindely, N., Laczi, K., Kristóffy, Z., Papp, C., Farkas, A., Tóth, L., Sáringer, S., Bodai, L., Rákhely, G., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.01273-24 · Cited by 6
“Rim101p, as a member of the Rim pathway, regulates antifungal drug tolerance proteins, such as Hsp90p and Ipt1p (62–65).”
Kiraz, N., Şen, S., Öz, Y., & Dağ, İ. (2022) · RENDICONTI LINCEI · doi:10.1007/s12210-022-01118-0 · Cited by 5
Hang, S., Wang, L., Ji, Z., Shen, X., Fang, X., Li, W., Jiang, Y., & Lu, H. (2025) · Antibiotics · doi:10.3390/antibiotics14080799 · Cited by 6
“…to the maintenance of azole tolerance and resistance in C. albicans [47,51] through several mechanisms, including its physical interaction with calcineurin [52,53], stabilization of Mkc1 signaling [54], modulation of ergosterol biosynthesis enzymes [47,55], and maintenance of Fks1 integrity [56].”
Padró-Villegas, L., & Mora-Montes, H. M. (2026) · Journal of Fungi · doi:10.3390/jof12060414 · Cited by 4
“…resistance through stabilization of signaling pathways, such as calcineurin and the protein phosphatase signaling pathway and the mitogen-activated protein kinase Mkc1 pathway (Pck1-MAPK), in which the transcription factor Crz1 is activated to confer echinocandin resistance [54,56,63,65,66].”
Stevens, I., Silao, F. G. S., Huch, S., Liu, H., Ryman, K., Carvajal-Jimenez, A., Ljungdahl, P. O., & Pelechano, V. (2024) · Scientific Reports · doi:10.1038/s41598-024-80435-w · Cited by 3
Immunomodulatory Agents as Adjunctive Therapy for the Treatment of Resistant Candida Species
Beyda, N. D., Regen, S., Lewis, R. E., & Garey, K. W. (2013) · Current Fungal Infection Reports · doi:10.1007/s12281-013-0132-3 · Cited by 3
“is a molecular chaperone that plays an important part in cell viability and response to stressful stimuli such as antifungal exposure [44, 45].”
BackgroundThe Hsp90 Chaperone Machinery: An Important Hub in Protein Interaction Networks
Radons, J. (2016) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2016/24631 · Cited by 4
“ch/) originate from two classes: steroid hormone receptors (SHRs) and protein kinases [23].”
BackgroundZheng, L., Xu, Y., Wang, C., Yang, F. J., Dong, Y., & Guo, L. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.01790-23 · Cited by 3
“Hsp70 is involved in the transfer of client proteins to Hsp90 for their subsequent activation via the Hsp90 chaperone cycle (44).”
BackgroundResultInfluentialYue, D., Zheng, D., Yang, L., Bai, Y., Song, Z., Li, D., 于晓芹, & Li, Y. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107370 · Cited by 4
The cell wall protein Rhd3/Pga29 is over-expressed inCandida albicansupon micafungin treatment
Vavala, E., Mignogna, G., Spano, F., Stringaro, A., Colone, M., Sanguinetti, M., Maras, B., & Angiolella, L. (2013) · Journal of Chemotherapy · doi:10.1179/1973947813y.0000000091 · Cited by 5
Host-Fungal Interactions: Pathogenicity versus Immunity
Tavanti, A., Naglik, J. R., & Osherov, N. (2012) · International Journal of Microbiology · doi:10.1155/2012/562480 · Cited by 5
Comparative Proteomic Analysis of Candida albicans and Candida glabrata
Prasad, T. S. K., Keerthikumar, S., Chaerkady, R., Kandasamy, K., Renuse, S., Marimuthu, A., Venugopal, A. K., Thomas, J. K., Jacob, H. K. C., Goel, R., et al. (2010) · Clinical Proteomics · doi:10.1007/s12014-010-9057-9 · Cited by 4
“albicans resulted in the decreased resistance to antifungal drugs including echinocandins [59, 60].”
Candida albicans Ssa: An Hsp70 Homologue and Virulence Factor
Puri, S., & Edgerton, M. (2013) · Heat shock proteins · doi:10.1007/978-94-007-6787-4_14 · Cited by 3
Yang, X., Ge, A., Zhou, H., Hu, C., Yang, X., Song, Z., & Xin, C. (2026) · Future Microbiology · doi:10.1080/17460913.2026.2656109 · Cited by 3
Day, A. W., & Kumamoto, C. A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0298724 · Cited by 4
Metadata
- Authors
- Singh, S. D., Robbins, N., Zaas, A. K., Schell, W. A., Perfect, J. R., & Cowen, L. E.
- Affiliations
- University of Toronto (CA)
- Duke Medical Center (US)
- Corresponding author
- Cowen, Leah E.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-07-31
- Volume
- 5
- Issue
- 7
- Pages
- e1000532
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC2712069
- OpenAlex
- W2087273774
- Cited by
- 362
- References
- 60
- Citations by year
- 2026: 19 · 2025: 26 · 2024: 14 · 2023: 25 · 2022: 24 · 2021: 28 · 2020: 23 · 2019: 18 · 2018: 18 · 2017: 18 · 2016: 20 · 2015: 16 · 2014: 32 · 2013: 25 · 2012: 23
- FWCI
- 12.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Burroughs Wellcome Fund
- University of Toronto
- National Institutes of Health
- Canadian Institutes of Health Research (MOP-86452)
- Natural Sciences and Engineering Research Council of Canada
- National Institute of Allergy and Infectious Diseases (AI 73896, R56AI028388, AI28388, R01AI073896, R01AI028388, K08AI065837)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- HSP90, calcineurin, Candida albicans, echinocandin resistance, antifungal resistance, candidiasis, Hsp90 client proteins, Crz1, calcineurin signaling, molecular chaperones, fungal cell wall biosynthesis, HSP90 inhibition, combination antifungal therapy, systemic candidiasis
- MeSH terms
- Micafungin, Analysis of Variance, Animals, Antifungal Agents, Azoles, Candida albicans, Candidiasis, Disease Models, Animal, DNA-Binding Proteins, Fungal Proteins, Male, Stress, Physiological, Transcription Factors, HSP90 Heat-Shock Proteins, Calcineurin, Drug Resistance, Fungal, Mice, Echinocandins, Lipopeptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.